Journal
VETERINARY SCIENCES
Volume 9, Issue 1, Pages -Publisher
MDPI
DOI: 10.3390/vetsci9010024
Keywords
ivermectin; antimicrobial resistance; proteomics; green veterinary pharmacology (GVP); immunomodulation
Categories
Ask authors/readers for more resources
Ivermectin has diverse functions and is particularly important in treating parasitic diseases in both human and veterinary medicine. It also has antibacterial, antiviral, and anti-inflammatory properties. Research is ongoing to understand its impact as an antimicrobial and immunomodulator.
Ivermectin has a wide number of many diverse functions. Certainly, it is irreplaceable for the treatment of parasitic pathologies in both human and veterinary medicine, and the latter represents the major field of its application. It has been called the drug for the world's poor because of its role as a saviour for those living on the margins of society, in underdeveloped areas afflicted by devastating and debilitating diseases, such as Onchocerciasis and Lymphatic filariasis. It showed huge, unexpected potential as an antibacterial (Chlamydia trachomatis and mycobacteria), and it has antiviral and anti-inflammatory properties. The research line described here is placed right in the middle of the investigation on the impact of this drug as an antimicrobial and an immunomodulator. Being a drug widely employed for mass administration, it is mandatory to broaden the knowledge of its possible interaction with bacterial growth and its generation of antimicrobial resistance. Equally, it is important to understand the impact of these drugs on the immune systems of animal species, e.g., horses and dogs, in which this drug is often used. More importantly, could immunomodulation and antibacterial activity promote both bacterial growth and the occurrence of resistance mechanisms?
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available